Monocarbonyl synthetic curcumin analogues with antitumour potential. Chemical and biological aspects

The antitumour activity of curcumin has been studied in detail, but this natural compound has not found application in oncology due to its unacceptable pharmacological properties. Currently, monocarbonyl analogues of curcumin, particularly C5-curcuminoids, are considered the most promising for cancer therapy due to their satisfactory pharmacokinetic profile. This review provides a critical analysis of recent literature on the synthesis of monocarbonyl analogues of curcumin and the study of their antitumour activity. Unlike previously published reviews, it examines not only the synthesis methods and chemical properties of these compounds but also the mechanisms of their biological action. The key molecular targets that promote angiogenesis, proliferation, and growth of malignant tumours and regulate glycolysis in neoplastic cells are discussed. The information provided in this review may be of interest to specialists in organic and medicinal chemistry, as well as biochemistry and pharmacology. The bibliography includes 168 references.

• Publication year

  2025

• Venue

  Russian Chemical Reviews

• Publication date

  2025-10-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.59761/rcr5189
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Design, synthesis and evaluation of diarylidenyl piperidone-ligated platinum (IV) complexes as chemoimmunotherapeutic agents.

  2025cited by this paper
• (E)-1-(3-(3-Hydroxy-4-Methoxyphenyl)-1-(3,4,5-Trimethoxyphenyl)allyl)-1H-1,2,4-Triazole and Related Compounds: Their Synthesis and Biological Evaluation as Novel Antimitotic Agents Targeting Breast Cancer

  2025cited by this paper
• The PI3K/Akt pathway: a target for curcumin’s therapeutic effects

  2025cited by this paper
• Curcumin mimics of potential chemoprevention with NQO1 induction properties

  2025cited by this paper
• Hybrid Nanoparticles Dual‐Loaded With Curcumin and Benzydamine Hydrochloride for the Treatment of Vulvovaginal Candidiasis: From Development to Biological Application In Vitro and In Vivo (Adv. Therap. 1/2025)

  2025cited by this paper
• Green nanotechnology: nanoparticle synthesis using Curcuma amada, Curcuma caesia, Curcuma longa, and Curcuma zedoaria

  2025cited by this paper
• Curcumin-mediated antimicrobial photodynamic therapy for inactivating Mycobacterium abscessus: a promising approach for non-tuberculous mycobacterial skin infections

  2025cited by this paper
• NF-κB in inflammation and cancer

  2025cited by this paper
• Clinical approaches to overcome PARP inhibitor resistance

  2025cited by this paper
• Synthesis, characterization, docking study and antiviral evaluation of new 3,5-Bis(benzylidene)piperidin-4-one Derivatives bearing phosphonate group

  2025cited by this paper
• Conjugates of 3,5-Bis(arylidene)-4-piperidone and Sesquiterpene Lactones Have an Antitumor Effect via Resetting the Metabolic Phenotype of Cancer Cells

  2024cited by this paper
• Antibiofilm Activity of Curcumin and Piperine and Their Synergistic Effects with Antifungals against Candida albicans Clinical Isolates

  2024cited by this paper
• Curcumin – Bioavailability Enhancement by Prodrug Approach and Novel Formulations

  2024cited by this paper
• Monoketone Curcuminoids: An Updated Review of Their Synthesis and Biological Activities

  2024cited by this paper
• Phytocompounds-based therapeutic approach: Investigating curcumin and green tea extracts on MCF-7 breast cancer cell line

  2024cited by this paper
• Exploring the molecular mechanisms of curcumin in modulating memory impairment in neurodegenerative disorders

  2024cited by this paper
• Combating tumor PARP inhibitor resistance: Combination treatments, nanotechnology, and other potential strategies.

  2024cited by this paper
• Dual Antioxidant and Cytotoxic Activities of Novel 1,2,3-Triazole-Decorated Unsymmetrical Monocarbonyl Curcumin Analogues

  2024cited by this paper
• Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales.

  2024cited by this paper
• A Review of Recent Curcumin Analogues and Their Antioxidant, Anti-Inflammatory, and Anticancer Activities

  2024cited by this paper
• Decreased Systemic Monocyte Colony Protein-1 (MCP-1) Levels and Reduced sCD14 Levels in Curcumin-Treated Patients with Moderate Anxiety: A Pilot Study

  2024cited by this paper
• Epigallocatechin gallate and curcumin inhibit Bcl-2: a pharmacophore and docking based approach against cancer

  2024cited by this paper
• The Effects of Fisetin and Curcumin on Oxidative Damage Caused by Transition Metals in Neurodegenerative Diseases

  2024cited by this paper
• Anticancer perspectives of monocarbonyl analogs of curcumin: A decade (2014–2024) review

  2024cited by this paper
• Methods to Improve the Solubility of Curcumin from Turmeric

  2023cited by this paper
• Toxicity Evaluation and Controlled-Release of Curcumin-Loaded Amphiphilic Poly-N-vinylpyrrolidone Nanoparticles: In Vitro and In Vivo Models

  2023cited by this paper
• Advances in β‐Diketocyclisation of Curcumin Derivatives and their Antitumor Activity

  2023cited by this paper
• Recent Development in the Structural Modifications of Monocarbonyl Analogues of Curcumin and their Improved Biological Activities: A Review

  2023cited by this paper
• Curcumin: a bioactive compound with molecular targets for human malignancies

  2023cited by this paper
• Anticarcinogenic Potency of EF24: An Overview of Its Pharmacokinetics, Efficacy, Mechanism of Action, and Nanoformulation for Drug Delivery

  2023cited by this paper
• Curcumin Disrupts a Positive Feedback Loop between ADMSCs and Cancer Cells in the Breast Tumor Microenvironment via the CXCL12/CXCR4 Axis

  2023cited by this paper
• Curcumin Reduces Hypoxia/Reperfusion Injury of Cardiomyocytes by Stimulating Vascular Endothelial Cells to Secrete FGF2.

  2023cited by this paper
• Curcumin promotes apoptosis of human melanoma cells by caspase 3

  2023cited by this paper
• Deciphering the Mysterious Relationship between the Cross-Pathogenetic Mechanisms of Neurodegenerative and Oncological Diseases

  2023cited by this paper
• A novel imidazo[1,2-a]pyridine derivative and its co-administration with curcumin exert anti-inflammatory effects by modulating the STAT3/NF-κB/iNOS/COX-2 signaling pathway in breast and ovarian cancer cell lines

  2023cited by this paper
• The effect of curcumin on hypoxia in the tumour microenvironment as a regulatory factor in cancer

  2023cited by this paper
• Integrated Transcriptome and Molecular Docking to Identify the Hub Superimposed Attenuation Targets of Curcumin in Breast Cancer Cells

  2023cited by this paper
• The Role of STATs in Ovarian Cancer: Exploring Their Potential for Therapy

  2023cited by this paper
• Curcumin and chemokines: mechanism of action and therapeutic potential in inflammatory diseases

  2023cited by this paper
• Monocarbonyl Analogs of Curcumin with Potential to Treat Colorectal Cancer

  2023cited by this paper
• Modulatory properties of curcumin in cancer: A narrative review on the role of interferons

  2023cited by this paper
• Curcumin analog, GO-Y078, induces HO-1 transactivation-mediated apoptotic cell death of oral cancer cells by triggering MAPK pathways and AP-1 DNA-binding activity

  2022cited by this paper
• Study of the Electrochemical Behavior of N-Substituted-4-Piperidones Curcumin Analogs: A Combined Experimental and Theoretical Approach

  2022cited by this paper
• Antioxidant, Antimicrobial, Cytotoxicity, and Larvicidal Activities of Selected Synthetic Bis-Chalcones

  2022cited by this paper
• EF‐24 inhibits TPA‐induced cellular migration and MMP‐9 expression through the p38 signaling pathway in cervical cancer cells

  2022cited by this paper
• Novel Unsymmetric 3,5-Bis(benzylidene)-4-piperidones That Display Tumor-Selective Toxicity

  2022cited by this paper
• A systems biology investigation of curcumin potency against TGF-β-induced EMT signaling in lung cancer

  2022cited by this paper
• Synthesis and Biological Testing of 3,5-Bis(arylidene)-4-piperidone Conjugates with 2,5-Dihydro-5H-1,2-oxaphospholenes.

  2022cited by this paper
• Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trapping

  2022cited by this paper
• Two novel piperidones induce apoptosis and antiproliferative effects on human prostate and lymphoma cancer cell lines

  2022cited by this paper
• Design of Novel Enantiopure Dispirooxindolopyrrolidine-Piperidones as Promising Candidates toward COVID-19: Asymmetric Synthesis, Crystal Structure and In Silico Studies

  2022cited by this paper
• Combined Curcumin and Luteolin Synergistically Inhibit Colon Cancer Associated with Notch1 and TGF-β Signaling Pathways in Cultured Cells and Xenograft Mice

  2022cited by this paper
• Dichloroacetyl Amides of 3,5-Bis(benzylidene)-4-piperidones Displaying Greater Toxicity to Neoplasms than to Non-Malignant Cells

  2022cited by this paper
• Targeting Glioblastoma Stem Cells to Overcome Chemoresistance: An Overview of Current Therapeutic Strategies

  2022cited by this paper
• Molecular Mechanism of Curcumin and Its Analogs as Multifunctional Compounds against Pancreatic Cancer

  2022cited by this paper
• Amphiphilic Poly-N-vinylpyrrolidone Nanoparticles as Carriers for Nonsteroidal, Anti-Inflammatory Drugs: Pharmacokinetic, Anti-Inflammatory, and Ulcerogenic Activity Study

  2022cited by this paper
• Synthesis, characterization and antichagasic evaluation of thiosemicarbazones prepared from chalcones and dibenzalacetones

  2021cited by this paper
• Design, Synthesis and Tumour-Selective Toxicity of Novel 1-[3-{3,5-Bis(benzylidene)-4-oxo-1-piperidino}-3-oxopropyl]-4-piperidone Oximes and Related Quaternary Ammonium Salts

  2021cited by this paper
• Curcumin induces apoptosis through caspase dependent pathway in human colon carcinoma cells

  2021cited by this paper
• Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer

  2021cited by this paper
• A Novel Hydroxamic Acid-Based Curcumin Derivative as Potent Histone Deacetylase Inhibitor for the Treatment of Glioblastoma

  2021cited by this paper
• Post-translational modifications of tubulin: their role in cancers and the regulation of signaling molecules

  2021cited by this paper
• The Role of Curcumin in Cancer Treatment

  2021cited by this paper
• Synthetic curcumin analog: inhibiting the invasion, angiogenesis, and metastasis in human laryngeal carcinoma cells via NF-kB pathway

  2021cited by this paper
• Demethoxycurcumin induces apoptosis in HER2 overexpressing bladder cancer cells through degradation of HER2 and inhibiting the PI3K/Akt pathway

  2021cited by this paper
• Curcumin promotes oligodendrocyte differentiation and their protection against TNF-α through the activation of the nuclear receptor PPAR-γ

  2021cited by this paper
• Curcumin potentiates laryngeal squamous carcinoma radiosensitivity via NF-ΚB inhibition by suppressing IKKγ expression

  2020cited by this paper
• Design and optimize N‐substituted EF24 as effective and low toxicity NF‐κB inhibitor for lung cancer therapy via apoptosis‐to‐pyroptosis switch

  2019cited by this paper
• Curcumin and Cancer

  2019cited by this paper
• Effects of curcumin on mitochondria in neurodegenerative diseases

  2019cited by this paper
• Novel hybrid molecules of 3,5-bis(benzylidene)-4-piperidones and dichloroacetic acid which demonstrate potent tumour-selective cytotoxicity.

  2019cited by this paper
• Mitochondria in Health and Disease

  2019cited by this paper
• Design, synthesis, and evaluation of a water soluble C5-monoketone type curcumin analogue as a potent amyloid β aggregation inhibitor.

  2019cited by this paper
• Diarylidenylpiperidones, H-4073 and HO-3867, Induce G2/M Cell-Cycle Arrest, Apoptosis and Inhibit STAT3 Phosphorylation in Human Pancreatic Cancer Cells

  2019cited by this paper
• Monocarbonyl curcumin analog A2 potently inhibits angiogenesis by inducing ROS-dependent endothelial cell death

  2019cited by this paper
• Orphan Drugs and Their Impact on Pharmaceutical Development.

  2018cited by this paper
• Curcumin as a potential candidate for treating hyperlipidemia: A review of cellular and metabolic mechanisms

  2018cited by this paper
• Bioactivities of EF24, a Novel Curcumin Analog: A Review

  2018cited by this paper
• Effects of curcumin-loaded PLGA nanoparticles on the RG2 rat glioma model.

  2017cited by this paper
• Synthesis and anti-tumor activity of EF24 analogues as IKKβ inhibitors.

  2017cited by this paper
• Medicinal attributes of 1,2,3-triazoles: Current developments.

  2017cited by this paper
• Utilization of curcumine and nanocurcumine compounds in cancer therapy

  2017cited by this paper
• Reversibility of the thia-Michael reaction of cytotoxic C5-curcuminoid and structure-activity relationship of bis-thiol-adducts thereof.

  2016cited by this paper
• EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma

  2016cited by this paper
• Synthesis and biological evaluation of some novel triazole hybrids of curcumin mimics and their selective anticancer activity against breast and prostate cancer cell lines.

  2016cited by this paper
• Curcumin-inspired cytotoxic 3,5-bis(arylmethylene)-1-(N-(ortho-substituted aryl)maleamoyl)-4-piperidones: A novel group of topoisomerase II alpha inhibitors.

  2015cited by this paper
• Modification of 3,5-bis(arylidene)-4-piperidone pharmacophore by phosphonate group using 1,2,3-triazole cycle as a linker for the synthesis of new cytostatics

  2015cited by this paper
• Anticancer Activity of Curcumin on Human Breast Adenocarcinoma: Role of Mcl-1 Gene

  2015cited by this paper
• 3,5-Bis(Arylidene)-4-Piperidones Modified by Bisphosphonate Groups as Novel Anticancer Agents

  2015cited by this paper
• Investigation of fatty acid conjugates of 3,5-bisarylmethylene-4-piperidone derivatives as antitumor agents and human topoisomerase-IIα inhibitors.

  2015cited by this paper
• Newly Designed and Synthesized Curcumin Analogs with in vitro Cytotoxicity and Tubulin Polymerization Activity

  2015cited by this paper
• Synthesis and biological evaluation of allylated and prenylated mono-carbonyl analogs of curcumin as anti-inflammatory agents.

  2014cited by this paper
• Curcumin analogues with high activity for inhibiting human prostate cancer cell growth and androgen receptor activation.

  2014cited by this paper
• The druggable genome: Evaluation of drug targets in clinical trials suggests major shifts in molecular class and indication.

  2014cited by this paper
• A Novel Curcumin Analog (H-4073) Enhances the Therapeutic Efficacy of Cisplatin Treatment in Head and Neck Cancer

  2014cited by this paper
• Ayurvedic Medicine for Rheumatoid Arthritis

  2014cited by this paper
• Topoisomerase inhibitors as anticancer agents: a patent update

  2013cited by this paper
• The Curcumin Analog EF24 Targets NF-κB and miRNA-21, and Has Potent Anticancer Activity In Vitro and In Vivo

  2013cited by this paper
• Molecular mechanisms of curcumin action: Gene expression

  2013cited by this paper
• Novel 3,5-bis(arylidene)-4-piperidone dimers: potent cytotoxins against colon cancer cells.

  2013cited by this paper

• Curcumin-Based Tri-Allyl Derivative for Bismaleimide Resins: Synergistic Modulation of Thermal Stability and Fire Safety

  2026cites this paper
• The Analgesic Effects of Nrf2 Activators in Chemotherapy-Induced Neuropathic Pain: Evidence from Animal Studies and Consequences for Translation into Clinical Trials.

  2026cites this paper